Liquidata Share/ETF/Trust Analysis
Portfolio Holdings Detail for ISIN IE00BF4RFH31
| Stock Name / Fund | iShares MSCI World Small Cap UCITS ETF USD (Acc) |
| Issuer | Blackrock |
| Entity holding fund | iShares III Public Limited Company |
| Entity Type | Umbrella investment company with variable capital and having segregated liability between its funds |
| Entity LEI | 549300PZLRJB7M8H1057 |
| ETF Ticker | WSML(USD) LSE |
| ETF Ticker | WLDS(GBP) LSE |
| ETF Ticker | IUSN(EUR) F |
| ETF Ticker | IUSN.DE(EUR) CXE |
| ETF Ticker | WLDS.LS(GBP) CXE |
| ETF Ticker | WSML.LS(USD) CXE |
| ETF Ticker | WSML.L(GBP) LSE |
| ETF Ticker | WLDS.L(GBP) LSE |
Holdings detail for GERN
| Stock Name | Geron Corporation |
| Ticker | GERN(USD) NASDAQ |
| TYPE | Common Stock |
| Country | USA |
| ISIN | US3741631036 |
| LEI | 549300T282D7Z2YESL90 |
Show aggregate GERN holdings
News associated with GERN
- Chicago Partners Investment Group LLC Grows Stock Position in Geron Corporation (NASDAQ:GERN)
- Chicago Partners Investment Group LLC grew its position in Geron Corporation (NASDAQ:GERN – Free Report) by 143.0% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 41,448 shares of the biopharmaceutical company’s stock after acquiring an additional 24,389 shares during […] - 2025-08-13 04:52:49
- Brokerages Set Geron Corporation (NASDAQ:GERN) PT at $4.19
- Shares of Geron Corporation (NASDAQ:GERN – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the nine research firms that are currently covering the company, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, three have issued a hold recommendation, four have issued a buy […] - 2025-08-12 02:30:48
- Universal Beteiligungs und Servicegesellschaft mbH Takes Position in Geron Corporation (NASDAQ:GERN)
- Universal Beteiligungs und Servicegesellschaft mbH purchased a new stake in shares of Geron Corporation (NASDAQ:GERN – Free Report) during the 1st quarter, HoldingsChannel reports. The fund purchased 39,643 shares of the biopharmaceutical company’s stock, valued at approximately $63,000. Several other hedge funds also recently modified their holdings of the company. Vanguard Group Inc. increased its […] - 2025-08-06 04:31:10
- Brokerages Set Geron Corporation (NASDAQ:GERN) Target Price at $4.61
- Shares of Geron Corporation (NASDAQ:GERN – Get Free Report) have been given a consensus rating of “Moderate Buy” by the ten analysts that are covering the stock, MarketBeat.com reports. One equities research analyst has rated the stock with a sell recommendation, three have assigned a hold recommendation, five have assigned a buy recommendation and one […] - 2025-07-18 02:22:58
- Sowell Financial Services LLC Invests $43,000 in Geron Corporation (NASDAQ:GERN)
- Sowell Financial Services LLC purchased a new position in shares of Geron Corporation (NASDAQ:GERN – Free Report) during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 27,000 shares of the biopharmaceutical company’s stock, valued at approximately $43,000. Several other institutional […] - 2025-06-24 05:18:52
- Exchange Traded Concepts LLC Grows Holdings in Geron Corporation (NASDAQ:GERN)
- Exchange Traded Concepts LLC lifted its position in shares of Geron Corporation (NASDAQ:GERN – Free Report) by 91.0% during the 1st quarter, HoldingsChannel reports. The fund owned 73,211 shares of the biopharmaceutical company’s stock after purchasing an additional 34,890 shares during the period. Exchange Traded Concepts LLC’s holdings in Geron were worth $116,000 at the […] - 2025-06-24 04:38:54
- Geron Corporation (NASDAQ:GERN) Given Average Rating of “Moderate Buy” by Brokerages
- Geron Corporation (NASDAQ:GERN – Get Free Report) has received an average rating of “Moderate Buy” from the nine brokerages that are covering the firm, Marketbeat.com reports. Three analysts have rated the stock with a hold rating, five have issued a buy rating and one has given a strong buy rating to the company. The average […] - 2025-06-20 03:08:48
- Geron Co. (NASDAQ:GERN) Shares Acquired by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
- UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its position in shares of Geron Co. (NASDAQ:GERN – Free Report) by 24.1% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,267,176 shares of the biopharmaceutical […] - 2025-06-04 05:00:53
- Geron Co. (NASDAQ:GERN) Receives $5.06 Average Target Price from Brokerages
- Shares of Geron Co. (NASDAQ:GERN – Get Free Report) have received an average rating of “Moderate Buy” from the nine research firms that are covering the stock, Marketbeat reports. Three research analysts have rated the stock with a hold recommendation, five have assigned a buy recommendation and one has assigned a strong buy recommendation to […] - 2025-05-29 02:27:25
- Deutsche Bank AG Grows Stake in Geron Co. (NASDAQ:GERN)
- Deutsche Bank AG increased its holdings in shares of Geron Co. (NASDAQ:GERN – Free Report) by 24.2% in the 4th quarter, HoldingsChannel.com reports. The firm owned 892,910 shares of the biopharmaceutical company’s stock after acquiring an additional 174,156 shares during the period. Deutsche Bank AG’s holdings in Geron were worth $3,161,000 at the end of […] - 2025-05-21 04:42:56
- Wedbush Forecasts Geron’s Q2 Earnings (NASDAQ:GERN)
- Geron Co. (NASDAQ:GERN – Free Report) – Equities researchers at Wedbush boosted their Q2 2025 earnings per share (EPS) estimates for Geron in a research note issued on Wednesday, May 7th. Wedbush analyst R. Driscoll now anticipates that the biopharmaceutical company will post earnings of ($0.02) per share for the quarter, up from their prior […] - 2025-05-13 03:04:50
- Geron Co. (NASDAQ:GERN) Shares Sold by The Manufacturers Life Insurance Company
- The Manufacturers Life Insurance Company lowered its holdings in Geron Co. (NASDAQ:GERN – Free Report) by 35.5% in the fourth quarter, HoldingsChannel reports. The firm owned 448,886 shares of the biopharmaceutical company’s stock after selling 246,649 shares during the quarter. The Manufacturers Life Insurance Company’s holdings in Geron were worth $1,589,000 as of its most […] - 2025-05-12 05:36:48
- Voya Investment Management LLC Has $872,000 Holdings in Geron Co. (NASDAQ:GERN)
- Voya Investment Management LLC grew its position in Geron Co. (NASDAQ:GERN – Free Report) by 30.8% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 246,282 shares of the biopharmaceutical company’s stock after purchasing an additional 58,034 shares during the period. Voya Investment Management LLC’s holdings in Geron were worth $872,000 at the end […] - 2025-05-07 06:32:51
- Integrated Wealth Concepts LLC Invests $36,000 in Geron Co. (NASDAQ:GERN)
- Integrated Wealth Concepts LLC acquired a new stake in shares of Geron Co. (NASDAQ:GERN – Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 10,285 shares of the biopharmaceutical company’s stock, valued at approximately $36,000. A number of other large […] - 2025-05-07 05:56:53
- Wells Fargo & Company MN Buys 71,697 Shares of Geron Co. (NASDAQ:GERN)
- Wells Fargo & Company MN grew its stake in Geron Co. (NASDAQ:GERN – Free Report) by 22.3% in the 4th quarter, Holdings Channel reports. The firm owned 392,696 shares of the biopharmaceutical company’s stock after purchasing an additional 71,697 shares during the period. Wells Fargo & Company MN’s holdings in Geron were worth $1,390,000 at […] - 2025-04-28 04:34:48
- Invesco Ltd. Sells 385,925 Shares of Geron Co. (NASDAQ:GERN)
- Invesco Ltd. reduced its position in shares of Geron Co. (NASDAQ:GERN – Free Report) by 15.7% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 2,077,602 shares of the biopharmaceutical company’s stock after selling 385,925 shares during the period. Invesco Ltd. owned […] - 2025-04-25 05:34:54
- JPMorgan Chase & Co. Decreases Position in Geron Co. (NASDAQ:GERN)
- JPMorgan Chase & Co. decreased its stake in Geron Co. (NASDAQ:GERN – Free Report) by 4.0% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 498,730 shares of the biopharmaceutical company’s stock after selling 20,944 shares during the quarter. JPMorgan Chase & Co.’s holdings […] - 2025-04-25 04:57:01
- Leerink Partnrs Predicts Geron’s Q2 Earnings (NASDAQ:GERN)
- Geron Co. (NASDAQ:GERN – Free Report) – Leerink Partnrs decreased their Q2 2025 earnings per share (EPS) estimates for shares of Geron in a research report issued to clients and investors on Monday, April 21st. Leerink Partnrs analyst F. Khurshid now anticipates that the biopharmaceutical company will earn ($0.04) per share for the quarter, down […] - 2025-04-24 02:52:48
- Renaissance Technologies LLC Takes Position in Geron Co. (NASDAQ:GERN)
- Renaissance Technologies LLC acquired a new position in shares of Geron Co. (NASDAQ:GERN – Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 1,452,700 shares of the biopharmaceutical company’s stock, valued at approximately $5,143,000. Several other institutional […] - 2025-04-21 04:46:47
- Geron Co. (NASDAQ:GERN) Stock Position Decreased by Alliancebernstein L.P.
- Alliancebernstein L.P. reduced its stake in shares of Geron Co. (NASDAQ:GERN – Free Report) by 49.2% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 625,291 shares of the biopharmaceutical company’s stock after selling 604,491 shares during the quarter. Alliancebernstein L.P.’s holdings in Geron were worth $2,214,000 as of its most recent SEC […] - 2025-04-17 04:29:03
- ExodusPoint Capital Management LP Purchases New Position in Geron Co. (NASDAQ:GERN)
- ExodusPoint Capital Management LP acquired a new position in shares of Geron Co. (NASDAQ:GERN – Free Report) during the 4th quarter, Holdings Channel.com reports. The firm acquired 106,441 shares of the biopharmaceutical company’s stock, valued at approximately $377,000. A number of other institutional investors and hedge funds have also bought and sold shares of the […] - 2025-04-13 05:57:04
- Geron Co. (NASDAQ:GERN) Shares Purchased by Sei Investments Co.
- Sei Investments Co. boosted its holdings in shares of Geron Co. (NASDAQ:GERN – Free Report) by 6.8% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 189,614 shares of the biopharmaceutical company’s stock after buying an additional 12,027 shares during the […] - 2025-04-09 04:58:43
- Geron Co. (NASDAQ:GERN) Receives $5.75 Consensus Price Target from Analysts
- Geron Co. (NASDAQ:GERN – Get Free Report) has been given an average rating of “Moderate Buy” by the eleven research firms that are covering the firm, MarketBeat Ratings reports. Three analysts have rated the stock with a hold recommendation, seven have given a buy recommendation and one has assigned a strong buy recommendation to the […] - 2025-04-09 02:05:01
- Geron (NASDAQ:GERN) Hits New 52-Week Low – Here’s What Happened
- Geron Co. (NASDAQ:GERN – Get Free Report) hit a new 52-week low during trading on Wednesday . The stock traded as low as $1.45 and last traded at $1.48, with a volume of 31179782 shares trading hands. The stock had previously closed at $1.59. Analyst Ratings Changes A number of research analysts have weighed in […] - 2025-04-02 05:14:53
- Corient Private Wealth LLC Grows Holdings in Geron Co. (NASDAQ:GERN)
- Corient Private Wealth LLC lifted its position in shares of Geron Co. (NASDAQ:GERN – Free Report) by 58.7% during the 4th quarter, HoldingsChannel reports. The fund owned 37,585 shares of the biopharmaceutical company’s stock after purchasing an additional 13,896 shares during the period. Corient Private Wealth LLC’s holdings in Geron were worth $133,000 at the […] - 2025-04-02 04:22:51
- Teacher Retirement System of Texas Purchases 39,933 Shares of Geron Co. (NASDAQ:GERN)
- Teacher Retirement System of Texas raised its position in shares of Geron Co. (NASDAQ:GERN – Free Report) by 35.7% during the fourth quarter, HoldingsChannel.com reports. The fund owned 151,887 shares of the biopharmaceutical company’s stock after buying an additional 39,933 shares during the quarter. Teacher Retirement System of Texas’ holdings in Geron were worth $538,000 […] - 2025-04-01 04:40:46
- Swiss National Bank Grows Position in Geron Co. (NASDAQ:GERN)
- Swiss National Bank raised its holdings in shares of Geron Co. (NASDAQ:GERN – Free Report) by 15.7% during the fourth quarter, HoldingsChannel reports. The firm owned 1,007,800 shares of the biopharmaceutical company’s stock after purchasing an additional 136,400 shares during the period. Swiss National Bank’s holdings in Geron were worth $3,568,000 as of its most […] - 2025-03-26 05:44:44
- Bank of New York Mellon Corp Sells 9,621 Shares of Geron Co. (NASDAQ:GERN)
- Bank of New York Mellon Corp lowered its position in shares of Geron Co. (NASDAQ:GERN – Free Report) by 0.6% during the fourth quarter, HoldingsChannel.com reports. The fund owned 1,649,422 shares of the biopharmaceutical company’s stock after selling 9,621 shares during the quarter. Bank of New York Mellon Corp’s holdings in Geron were worth $5,839,000 […] - 2025-03-17 06:01:01
- Geron (NASDAQ:GERN) versus Dermata Therapeutics (NASDAQ:DRMA) Head-To-Head Review
- Geron (NASDAQ:GERN – Get Free Report) and Dermata Therapeutics (NASDAQ:DRMA – Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, profitability, valuation, institutional ownership, analyst recommendations, risk and dividends. Analyst Recommendations This is a summary of current […] - 2025-03-12 04:10:56
- B. Riley Comments on Geron’s FY2027 Earnings (NASDAQ:GERN)
- Geron Co. (NASDAQ:GERN – Free Report) – B. Riley decreased their FY2027 earnings estimates for shares of Geron in a research note issued to investors on Tuesday, February 18th. B. Riley analyst K. Patel now forecasts that the biopharmaceutical company will post earnings of $0.28 per share for the year, down from their prior forecast […] - 2025-02-21 06:30:52
iShares MSCI World Small Cap UCITS ETF USD (Acc) GERN holdings
| Date | Number of GERN Shares Held | Base Market Value of GERN Shares | Local Market Value of GERN Shares | Change in GERN Shares Held | Change in GERN Base Value | Current Price per GERN Share Held | Previous Price per GERN Share Held |
|---|
| 2025-10-15 (Wednesday) | 376,511 | USD 481,934 | USD 481,934 | | | | |
| 2025-10-10 (Friday) | 374,036 | USD 489,987 | USD 489,987 | | | | |
| 2025-10-08 (Wednesday) | 374,036 | USD 516,170 | USD 516,170 | | | | |
| 2025-10-07 (Tuesday) | 374,036 | USD 482,506 | USD 482,506 | 1,648 | USD 5,849 | USD 1.29 | USD 1.28 |
| 2025-10-06 (Monday) | 372,388 | USD 476,657 | USD 476,657 | 0 | USD -26,067 | USD 1.28 | USD 1.35 |
| 2025-10-03 (Friday) | 372,388 | USD 502,724 | USD 502,724 | 0 | USD -11,171 | USD 1.35 | USD 1.38 |
| 2025-10-02 (Thursday) | 372,388 | USD 513,895 | USD 513,895 | 0 | USD -11,172 | USD 1.38 | USD 1.41 |
| 2025-10-01 (Wednesday) | 372,388 | USD 525,067 | USD 525,067 | 0 | USD 14,895 | USD 1.41 | USD 1.37 |
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdingsShare Trades of GERN by Blackrock for IE00BF4RFH31
Show aggregate share trades of GERN| Date | Action | Quantity | Market High | Market Low | Likely Trade Price | Likely Trade Value (Profit/Loss) | Average Price previous trades |
|---|
| 2025-10-07 | BUY | 1,648 | | | 1.290* | | 2.32 |
| 2025-09-08 | SELL | -3,248 | | | 1.370* | | 2.37 Profit of 7,683 on sale |
| 2025-08-15 | BUY | 1,614 | | | 1.450* | | 2.37 |
| 2025-08-07 | BUY | 4,890 | | | 1.300* | | 2.38 |
| 2025-07-29 | BUY | 1,624 | | | 1.135* | | 2.42 |
| 2025-07-14 | BUY | 3,268 | | | 1.340* | | 2.47 |
| 2025-06-30 | BUY | 3,232 | | | 1.410* | | 2.51 |
| 2025-06-25 | BUY | 4,842 | | | 1.520* | | 2.53 |
| 2025-06-20 | SELL | -816 | | | 1.510* | | 2.55 Profit of 2,083 on sale |
| 2025-06-12 | SELL | -6,536 | | | 1.560* | | 2.59 Profit of 16,950 on sale |
| 2025-06-02 | BUY | 2,478 | | | 1.430* | | 2.65 |
| 2025-05-28 | BUY | 1,644 | | | 1.450* | | 2.68 |
| 2025-05-14 | BUY | 825 | | | 1.190* | | 2.78 |
| 2025-05-13 | BUY | 1,656 | | | 1.200* | | 2.79 |
| 2025-05-07 | BUY | 2,472 | | | 1.310* | | 2.84 |
| 2025-04-28 | BUY | 812 | | | 1.400* | | 2.92 |
| 2025-04-16 | BUY | 10,686 | | | 1.240* | | 3.04 |
| 2025-04-14 | BUY | 1,630 | | | 1.320* | | 3.07 |
| 2025-04-08 | SELL | -1,638 | | | 1.280* | | 3.14 Profit of 5,140 on sale |
| 2025-04-04 | SELL | -1,650 | | | 1.380* | | 3.17 Profit of 5,234 on sale |
| 2025-03-28 | BUY | 8,090 | | | 1.650* | | 3.24 |
| 2025-03-12 | SELL | -1,636 | | | 1.770* | | 3.45 Profit of 5,643 on sale |
| 2025-03-04 | SELL | -1,618 | | | 1.660* | | 3.56 Profit of 5,760 on sale |
| 2025-02-27 | SELL | -3,156 | | | 1.740* | | 3.63 Profit of 11,457 on sale |
| 2025-02-13 | BUY | 795 | | | 2.790* | | 3.80 |
| 2025-02-12 | BUY | 3,176 | | | 2.790* | | 3.82 |
| 2025-01-27 | BUY | 782 | | | 2.960* | | 4.02 |
| 2025-01-23 | BUY | 782 | | | 3.020* | | 4.05 |
| 2024-12-09 | BUY | 27,936 | | | 3.980* | | 4.10 |
| 2024-12-04 | BUY | 1,544 | | | 4.000* | | 4.11 |
| 2024-12-03 | BUY | 2,316 | | | 3.950* | | 4.11 |
| 2024-11-19 | BUY | 4,668 | | | 3.790* | | 4.13 |
| 2024-11-18 | BUY | 1,554 | | | 3.780* | | 4.14 |
| 2024-11-12 | BUY | 3,072 | | | 3.970* | | 4.15 |
| 2024-11-11 | BUY | 768 | | | 4.120* | | 4.15 |
| 2024-11-11 | BUY | 768 | | | 4.120* | | 4.15 |
| 2024-11-07 | BUY | 3,820 | | | 4.290* | | 4.13 |
| 2024-11-07 | BUY | 3,820 | | | 4.290* | | 4.13 |
| 2024-10-23 | BUY | 1,528 | | | 4.070* | | 3.98 |
| 2024-10-23 | BUY | 1,528 | | | 4.070* | | 3.98 |
Market high and low price is on the date. * (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection
The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close
Shorting History of GERN
| Date | Shorted Volume | Short Exempt Volume | Total Shares Traded | % Shorted |
|---|
| 2025-09-19 | 2,515,106 | 0 | 3,740,438 | 67.2% |
| 2025-09-18 | 837,549 | 0 | 1,824,574 | 45.9% |
| 2025-09-17 | 1,542,051 | 168,238 | 3,124,418 | 49.4% |
| 2025-09-16 | 2,400,289 | 11,575 | 6,738,651 | 35.6% |
| 2025-09-15 | 1,081,359 | 2,459 | 2,068,029 | 52.3% |
| 2025-09-12 | 986,362 | 6,717 | 2,109,457 | 46.8% |
| 2025-09-11 | 898,249 | 5,403 | 1,970,185 | 45.6% |
| 2025-09-10 | 1,471,855 | 4,700 | 3,276,645 | 44.9% |
| 2025-09-09 | 795,635 | 0 | 1,617,206 | 49.2% |
| 2025-09-08 | 1,092,963 | 0 | 2,461,460 | 44.4% |
| 2025-09-05 | 1,377,462 | 0 | 2,628,294 | 52.4% |
| 2025-09-04 | 833,959 | 0 | 1,973,147 | 42.3% |
| 2025-09-03 | 1,842,273 | 0 | 3,508,587 | 52.5% |
| 2025-09-02 | 1,650,277 | 0 | 6,196,011 | 26.6% |
| 2025-08-29 | 562,611 | 0 | 1,306,284 | 43.1% |
| 2025-08-28 | 706,516 | 0 | 2,242,927 | 31.5% |
| 2025-08-27 | 651,205 | 897 | 2,164,660 | 30.1% |
| 2025-08-26 | 569,566 | 0 | 1,191,667 | 47.8% |
| 2025-08-25 | 1,129,368 | 0 | 2,628,161 | 43.0% |
| 2025-08-22 | 819,842 | 0 | 2,807,481 | 29.2% |
| 2025-08-21 | 666,480 | 0 | 1,642,442 | 40.6% |
| 2025-08-20 | 871,706 | 0 | 2,319,497 | 37.6% |
| 2025-08-19 | 1,021,818 | 0 | 2,200,468 | 46.4% |
| 2025-08-18 | 3,358,185 | 25,435 | 9,466,348 | 35.5% |
| 2025-08-15 | 1,044,910 | 0 | 5,769,724 | 18.1% |
| 2025-08-14 | 1,157,684 | 0 | 3,848,674 | 30.1% |
| 2025-08-13 | 2,067,814 | 1 | 9,350,057 | 22.1% |
| 2025-08-12 | 2,056,337 | 3,000 | 4,869,490 | 42.2% |
| 2025-08-11 | 3,715,457 | 780 | 8,173,658 | 45.5% |
| 2025-08-08 | 2,304,632 | 13,937 | 6,047,210 | 38.1% |
| 2025-08-07 | 4,191,135 | 136 | 7,214,915 | 58.1% |
| 2025-08-06 | 9,139,825 | 323 | 14,305,976 | 63.9% |
| 2025-08-05 | 2,193,050 | 2,046 | 4,314,894 | 50.8% |
| 2025-08-04 | 3,706,615 | 4,795 | 7,140,216 | 51.9% |
| 2025-08-01 | 3,110,509 | 1,315 | 5,312,388 | 58.6% |
| 2025-07-31 | 4,183,352 | 19,558 | 6,611,710 | 63.3% |
| 2025-07-30 | 2,471,958 | 405 | 4,107,757 | 60.2% |
| 2025-07-29 | 3,051,391 | 373,042 | 6,058,938 | 50.4% |
| 2025-07-28 | 4,989,387 | 56,705 | 12,385,616 | 40.3% |
| 2025-07-25 | 1,802,775 | 14,334 | 4,041,697 | 44.6% |
| 2025-07-24 | 3,786,610 | 2,550 | 6,366,263 | 59.5% |
| 2025-07-23 | 2,262,039 | 13,166 | 6,252,459 | 36.2% |
| 2025-07-22 | 2,057,783 | 1,346 | 3,951,860 | 52.1% |
| 2025-07-21 | 1,878,374 | 16,199 | 5,441,595 | 34.5% |
| 2025-07-18 | 1,907,220 | 5,370 | 2,860,660 | 66.7% |
The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.
Back to Listing
Disclaimer
All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.